يعرض 1 - 2 نتائج من 2 نتيجة بحث عن '"NHEJ, non-homologous end-joining"', وقت الاستعلام: 0.61s تنقيح النتائج
  1. 1

    المصدر: Acta Pharmaceutica Sinica B, Vol 11, Iss 10, Pp 2973-2982 (2021)
    Acta Pharmaceutica Sinica. B

  2. 2

    المؤلفون: Liwu Fu, Hong Zhang

    المصدر: Acta Pharmaceutica Sinica B, Vol 11, Iss 6, Pp 1400-1411 (2021)
    Acta Pharmaceutica Sinica. B

    مصطلحات موضوعية: FANCD2, Fanconi anemia protein, DFS, disease-free survival, HNC, head and neck cancer, Cancer therapy, Review, medicine.disease_cause, SCC, squamous cell carcinoma, Metastasis, εPKC, epsilon protein kinase C, 0302 clinical medicine, NAD, nicotinamide adenine dinucleotide, Polymorphism (computer science), PdG, N2-propano-2′-deoxyguanosine, EC, esophageal cancer, General Pharmacology, Toxicology and Pharmaceutics, FA, Fanconi anemia, Cancer, TGF-β, transforming growth factor β, 0303 health sciences, Progression, GCA, gastric cancer, NRF2, nuclear factor erythroid 2 (NF-E2)-related factor 2, ccRCC, clear-cell renal cell carcinomas, NHEJ, non-homologous end-joining, PC, pancreatic cancer, 030220 oncology & carcinogenesis, CRC, colorectal cancer, NeG, 1,N2-etheno-dGuo, PBMC, peripheral blood mononuclear cell, ALD, alcoholic liver disease, CSCs, cancer stem cells, OvCa, ovarian cancer, COUP-TF, chicken ovalbumin upstream promoter-transcription factor, BCa, bladder cancer, NF-κB, nuclear factor-κB, Single-nucleotide polymorphism, Acetaldehyde, RM1-950, 4-HNE, 4-hydroxy-2-nonenal, OS, overall survival, 03 medical and health sciences, NSCLC, non-small-cell lung, medicine, SNP, MN, micronuclei, Polymorphism, ALDH2, 030304 developmental biology, LCSCs, liver cancer stem cells, MDA, malondialdehyde, business.industry, ALDH2, aldehyde dehydrogenase 2, MDR, multi-drug resistance, OPC, oropharyngeal cancer, HDACs, histone deacetylases, medicine.disease, AMPK, AMP-activated protein kinase, VHL, von Hippel-Lindau, Tumor progression, REV1, Y-family DNA polymerase, NER, nucleotide excision repair pathway, NRRE, nuclear receptor response element, Tumorigenesis, Cancer research, NCEs, normochromic erythrocytes, Therapeutics. Pharmacology, HR, homologous recombination, HCC, hepatocellular carcinoma, business, Carcinogenesis, HNF-4, hepatocyte nuclear factor 4